Urology Doctors in Decatur, GA Accepting Medicare

9 Urology doctors found. Showing 1 - 9

Hemant Chaparala, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2711 Irvin Way, Decatur, GA 30030 Phone: 678-344-8900

Dr. Michael Kemper, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2685 Milscott Dr, Decatur, GA 30033 Phone: 404-292-3727

Dr. Lambda P Msezane, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2685 Milscott Dr, Decatur, GA 30033 Phone: 404-292-3727    Fax: 404-294-9674

Dr. Karl L Pete, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2711 Irvin Way Ste 102, Decatur, GA 30030 Phone: 678-344-8900    Fax: 678-619-5240

Ms. Lois Elayne Miller, RN Urology Medicare: Not Enrolled in Medicare Practice Location: 1670 Clairmont Rd, Decatur, GA 30033 Phone: 404-728-4125

Dr. Muta M. Issa, MD, MBA Urology Medicare: Medicare Enrolled Practice Location: 1670 Clairmont Rd, Avamc / Urology (112), Decatur, GA 30033 Phone: 404-728-4129    Fax: 404-329-2201

Daniel J. Canter, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2685 Milscott Dr, Decatur, GA 30033 Phone: 404-292-3727

Walter Z Falconer, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2685 Milscott Dr, Decatur, GA 30033 Phone: 404-292-3727    Fax: 404-294-9674

Dr. Syed Mohammad Akbar Jafri, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3002 Mount Olive Dr, Decatur, GA 30033 Phone: 404-217-5762

News Archive

Could hormone therapy for prostate cancer increase the risk of Alzheimer's disease?

Men who take hormone-blocking therapy (ADT) for prostate cancer may be at an increased risk of developing dementia and Alzheimer's disease.

FDA launches workshop to simplify orphan drug development

The U.S. Food and Drug Administration (FDA) has announced the launch of an orphan drug workshop series-an opportunity for biotechnology companies, pharmaceutical firms, academics and other interested parties to spend two days creating applications for orphan status designation, under the guidance of staff from FDA's Office of Orphan Products Development (OOPD).

Study: People with IDD living in residential group homes more likely to die from COVID-19

A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities living in residential group homes are more likely to be diagnosed with COVID-19 and die from the virus than those without IDD.

Lidocaine benefits breast cancer survivors who experience pain during intercourse

Scientists at Oregon Health & Science University report that breast cancer survivors who experience pain during sexual intercourse, a common side effect of breast cancer treatment, may achieve comfort when liquid lidocaine is applied strategically to prevent pain.

Read more Medical News

› Verified 1 days ago